
Dual GIP/GLP-1 Receptor Agonist
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist peptide. Biolyn supplies research-grade and API-grade Tirzepatide to qualified pharmaceutical developers and research institutions.
A 39-amino acid synthetic peptide with a C20 fatty diacid moiety. Acts as a dual incretin receptor agonist with preferential GIP receptor activity.